Iveth Miranda-Abarca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Iveth Miranda-Abarca has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Maycol Suker Ccorahua-Rios
Estudiante de Medicina
2 shared publications - Noé Atamari-Anahui
Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Perú
2 shared publications - Andy Bryan Campero-Espinoza
ASOCIEMH CUSCO, Escuela Profesional de Medicina Humana, Facultad de Ciencias de la Salud, Universidad Nacional de San Antonio Abad del Cusco, Cusco, Perú. ORCID: 0000-0003-1333-8118
1 shared publication - Carlos A. Orellana-Siuce
Instituto Nacional de Salud del Niño-Breña, Lima, Perú
1 shared publication - César Johan Pereira-Victorio
Departamento de Ciencias Médicas, Facultad de Ciencias de la Salud, Universidad de Castilla-La Mancha, Ciudad Real, Spain
1 shared publication - Evelina Andrea Rondón-Abuhadba
Universidad Nacional de San Antonio Abad del Cusco
1 shared publication
Latest Publications
- 30 June 2021
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 41 (2) , 121
Hepatitis por citomegalovirus en una lactante de 2 meses: reporte de un caso
La infección por citomegalovirus congénito es una causa de infección neonatal que puede cursar asintomático; sin embargo, es posible sus complicaciones en algunos órganos como el sistema nervioso y el hígado. Reportamos un caso de una lactante mujer de 2 meses, con hepatitis por citomegalovirus caracterizado por distensión abdominal, colestasis, irritabilidad y pobre lactancia. En los exámenes se evidenció compromiso hepático, microcalcificaciones periventriculares e hipoacusia neurosensorial. El diagnóstico se determinó mediante anticuerpos séricos, confirmado con carga viral en sangre, orina y en tejido hepático. Se administró tratamiento con ganciclovir, vitamina K y ácido ursodesoxicólico con adecuada evolución. La hepatitis por citomegalovirus es una complicación que puede estar asociado con el compromiso de otros órganos. El tratamiento antiviral para el compromis stá recomendado en menores de un mes si está asociado a daño neurológico.
- 30 June 2021
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 41 (2) , 121
Hepatitis por citomegalovirus en una lactante de 2 meses: reporte de un caso
La infección por citomegalovirus congénito es una causa de infección neonatal que puede cursar asintomático; sin embargo, es posible sus complicaciones en algunos órganos como el sistema nervioso y el hígado. Reportamos un caso de una lactante mujer de 2 meses, con hepatitis por citomegalovirus caracterizado por distensión abdominal, colestasis, irritabilidad y pobre lactancia. En los exámenes se evidenció compromiso hepático, microcalcificaciones periventriculares e hipoacusia neurosensorial. El diagnóstico se determinó mediante anticuerpos séricos, confirmado con carga viral en sangre, orina y en tejido hepático. Se administró tratamiento con ganciclovir, vitamina K y ácido ursodesoxicólico con adecuada evolución. La hepatitis por citomegalovirus es una complicación que puede estar asociado con el compromiso de otros órganos. El tratamiento antiviral para el compromis stá recomendado en menores de un mes si está asociado a daño neurológico.
- Open Access
- 30 November 2019
- Published by Medwave Estudios Limitada in Medwave
- Vol. 19 (10) , e7723
Type 2 diabetes mellitus prevalence between 2005 and 2018 in population under 30 using data from the Ministry of Health of Peru
Type 2 diabetes mellitus is a health problem in low and middle-income countries like Peru. There are few published reports on trends and surveillance of this disease in the young Peruvian population. To describe the prevalence of type 2 diabetes mellitus in the population under 30 registered between 2005 and 2018 by the Ministry of Health of Peru. A descriptive study was conducted from a secondary analysis of the national registries of type 2 diabetes (ICD 10: E11) in the population under 30 treated in the health facilities of the Ministry of Health of Peru between 2015 and 2018. Described by department and geographic region, the prevalence of diabetes was adjusted for age and sex. In the period between 2005 and 2018, the national prevalence of type 2 diabetes mellitus increased from 2.1 to 22.1 cases/100 000 population. Women had a higher prevalence. Geographic regions with the highest prevalence increase were the Coast from 3.8 to 35.3/100 000 population and the Rainforest from 1.1 to 22.1/100 000 population. In the same period, the departments with the highest prevalence increase were Cajamarca (1733.3%) and Puno (1704.2%). Furthermore, Tumbes, Ica, Lambayeque, Callao, Lima, Loreto, and Madre de Dios reported prevalence rates over the national average. The prevalence of type 2 diabetes mellitus in the population under 30 and covered by the Peruvian Ministry of Health has increased more than ten times in the period between 2005 and 2018. The Coast and the cities with the highest population density had the highest prevalence. A greater focus to improve the strategies of risk factor control in the population under 30 is needed, including preventive actions on obesity and inadequate lifestyles, as well as a screening at a younger age for diabetes in the population at risk.
- 30 November 2019
- Published by Medwave Estudios Limitada in Medwave
- Vol. 19 (10) , e7723
Open AccessType 2 diabetes mellitus prevalence between 2005 and 2018 in population under 30 using data from the Ministry of Health of Peru
Type 2 diabetes mellitus is a health problem in low and middle-income countries like Peru. There are few published reports on trends and surveillance of this disease in the young Peruvian population. To describe the prevalence of type 2 diabetes mellitus in the population under 30 registered between 2005 and 2018 by the Ministry of Health of Peru. A descriptive study was conducted from a secondary analysis of the national registries of type 2 diabetes (ICD 10: E11) in the population under 30 treated in the health facilities of the Ministry of Health of Peru between 2015 and 2018. Described by department and geographic region, the prevalence of diabetes was adjusted for age and sex. In the period between 2005 and 2018, the national prevalence of type 2 diabetes mellitus increased from 2.1 to 22.1 cases/100 000 population. Women had a higher prevalence. Geographic regions with the highest prevalence increase were the Coast from 3.8 to 35.3/100 000 population and the Rainforest from 1.1 to 22.1/100 000 population. In the same period, the departments with the highest prevalence increase were Cajamarca (1733.3%) and Puno (1704.2%). Furthermore, Tumbes, Ica, Lambayeque, Callao, Lima, Loreto, and Madre de Dios reported prevalence rates over the national average. The prevalence of type 2 diabetes mellitus in the population under 30 and covered by the Peruvian Ministry of Health has increased more than ten times in the period between 2005 and 2018. The Coast and the cities with the highest population density had the highest prevalence. A greater focus to improve the strategies of risk factor control in the population under 30 is needed, including preventive actions on obesity and inadequate lifestyles, as well as a screening at a younger age for diabetes in the population at risk.